4Djaldetti R,Achirm A,Ziv I,et al.Lympyocyte ultrastructure in patients with multiple sclerosis[J].Biomed Pharmacother,1995,49(6):300-303.
5Tenser RB,Hay KA,Aberg JA.Immunoglobulin Gimmunosuppression of multiple sclerosis.Suppression of all three majior lymphocyte subsets[J].Arch Neurol,1993,50(4):417-420.
3Werner P, Pitt D, Raine CS, et al. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage[J]. Ann Neurol, 2001,50(2):169-180.
4McDonald WI, Compston A, Edan G, et al. Reco-mmended diagnostic criteria for multiple sclerosis: guidelines from the Internaltional Penel no the diagnosis of multiple sclerosis[J]. Ann Neurol, 2001,50(1):121-127.
5Ramsaransing G,Maurits N,Zwanikken C,et al. Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review[J]. Mult Scler, 2001,7(5):345-347.
6Ng SH,Ko SF,Cheung YC,et al. MRI features of Balo's concentric sclerosis[J]. Br J Radiol, 1999,72(856):400-403.
7Schwarz S, Mohr A, Knauth M, et al. Acute dissiminated encephalomyelitis:a follow-up study of 40 adult patients[J]. Neurology, 2001,56(10):1313-1318.
8Walsh P, Kane N, Butler S. The clinical role of evoked potentials [ J ]. J Neurol Neurosurg Psychiatry,2005,76 (suppl 2) :S16 -S22.
9Korn T.Pathophysiology of multiple sclerosis[J].Neurol,2008,255(S)16:2-6.
10Achiron R,Gilad R,Margalit,et al.Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis:delineation of usage and mode of action[J].Journal of Neurology,Neurosurgery,and Psychiatry,1994,57(S):57-61.
